Clinical Trial

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Name: A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer — clinical trial record (NCT07454720)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The study is being conducted to evaluate the safety and efficacy of Adebrelimab and SHR-8068 in combination with chemoradiotherapy in subjects with rectal cancer.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-06

Trial Details

NCT Number	NCT07454720
Lead Sponsor	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions	Locally Advanced Resectable Rectal Cancer
Enrollment	165 participants
Start Date	2026-03-23
Primary Completion	2032-11 (estimated)
Study Completion	2035-11 (estimated)
Updated on ClinicalTrials.gov	2026-05-05